UGP-CRMEIAS — Cross-reference investigation Universal Gender Programs Civil Rights, Medical Ethics & Institutional Accountability Intelligence System

.

### IBM RESEARCH AND INNOVATION PROPOSAL

### Universal Gender Programs Civil Rights, Medical Ethics & Institutional Accountability Intelligence System

Project Acronym: UGP-CRMEIAS

Submission Category: Artificial Intelligence, Responsible AI, Healthcare Technology, Human Rights, Digital Forensics, Institutional Governance, Public-Sector Accountability

Proposed Applicant: Tyrone Bostick

Proposed Technical Lead: To be confirmed

Proposed Organization: Independent research initiative; legal entity and institutional partners not yet established

Proposed Research Partner: IBM Research — proposed, not confirmed

Proposed Funding Status: Seeking research collaboration, technical evaluation, and potential pilot funding

Project Stage: Research and development proposal

Initial Deployment Model: Controlled research pilot using public records and lawfully obtained, appropriately protected evidence

Primary Objective: Develop an AI-assisted evidence intelligence platform that identifies, documents, cross-references, and audits potential civil-rights violations, medical-consent failures, institutional misconduct, financial incentives, and accountability gaps in gender-related and reproductive-health programs worldwide.

### 1\. Executive Summary

UGP-CRMEIAS proposes a secure, explainable artificial-intelligence platform for investigating institutional practices that may violate civil rights, informed-consent requirements, medical ethics, privacy protections, or human-subject research standards.

The system will analyze lawfully obtained public records, court decisions, government investigations, legislative hearings, audit reports, procurement documents, institutional policies, clinical consent materials, and other authorized evidence.

Its central purpose is to help qualified researchers, civil-rights organizations, attorneys, auditors, medical ethicists, and public institutions answer five questions:

* What conduct has been documented, alleged, or independently verified?

* Which institutions, policies, contractors, funding sources, and oversight bodies were involved?

* Were financial incentives, quotas, cost-saving pressures, or performance targets connected to the conduct?

* Were consent, medical safety, due process, privacy, and individual rights adequately protected?

* What records, investigations, or corrective actions remain outstanding?

The platform will not presume that a gender-related program is unlawful because of its subject matter, nor will it classify individuals or organizations as guilty based on automated analysis. It will identify evidence, relationships, inconsistencies, and research leads for qualified human review.

The project is designed to address a significant institutional accountability problem: important information is frequently distributed across different agencies, jurisdictions, legal proceedings, financial records, medical oversight systems, and historical archives. Investigators may struggle to connect those records or distinguish proven findings from allegations and unsupported interpretations.

UGP-CRMEIAS will provide a structured, auditable method for conducting that work.

### 2\. Statement of the Problem

Historical and contemporary investigations have documented serious concerns involving reproductive coercion, forced sterilization, inadequate informed consent, discriminatory medical practices, unethical experimentation, and failures of institutional oversight.

Examples of documented matters include:

* Peru: Government investigations and congressional records described sterilization targets and quotas, pressure on health workers, failures of informed consent, and inadequate postoperative care. The Peruvian congressional investigation reported that program targets were converted into mandatory quotas and that incentives and sanctions were used. www2.congreso.gob.pe +2

* California: A 2014 State Auditor report identified 144 female inmates who underwent sterilization procedures during the reviewed period and deficiencies in the informed-consent process in 39 cases. The auditor's legal counsel considered it likely that a court would conclude consent was not lawfully obtained in those 39 cases. This was an audit finding, not a court judgment on every procedure. information.auditor.ca.gov +1

* North Carolina: The state established a task force to address compensation for people forcibly sterilized under its former eugenics program and preserved historical records relevant to the program. NC DOA +1

* Japan: In 2024, Japan's Supreme Court found provisions of the former Eugenic Protection Act unconstitutional and found the state's legislative conduct unlawful for purposes of redress. The ruling addressed a historical state program and its legal consequences. courts.go.jp +1

* Greenland and Denmark: Women and girls have reported receiving contraception without informed consent. Governments have acknowledged harmful practices and issued apologies. However, the question of whether there was an intentional, systematic policy to insert IUDs without consent or limit population growth remains disputed in the available expert record. OHCHR +1

These cases illustrate different legal systems, time periods, institutions, and forms of alleged or established misconduct. They do not, by themselves, demonstrate a single international coordinating organization or a unified motive.

### The technology gap

Existing research workflows often lack a unified method to:

* Connect court findings with government audits and financial records.

* Identify when institutional targets become individual performance quotas.

* Trace payments, procurement, grants, reimbursements, and compensation.

* Detect missing consent records and inconsistent versions of policies.

* Distinguish official findings from allegations and secondary reporting.

* Identify which oversight agencies received complaints and what action followed.

* Preserve the original source and chain of custody for every research conclusion.

* Compare legal standards across jurisdictions without incorrectly treating them as identical.

UGP-CRMEIAS addresses this gap through an evidence-first intelligence and accountability architecture.

### 3\. Research Goals and Objectives

Goal 1 — Evidence integrity

Create a searchable, source-linked evidence repository in which every extracted claim can be traced to its originating document, page, paragraph, date, and issuing authority.

Goal 2 — Institutional relationship analysis

Identify documented relationships among government departments, healthcare providers, contractors, facilities, funding bodies, professional organizations, oversight authorities, and other relevant institutions.

Goal 3 — Financial-forensics analysis

Detect and investigate possible connections between program funding, performance targets, provider payments, procurement, financial incentives, cost-reduction strategies, and reported misconduct.

Goal 4 — Medical ethics and consent review

Develop structured tools for reviewing informed-consent procedures, patient autonomy, coercion indicators, documentation deficiencies, clinical safeguards, and access to remedies.

Goal 5 — Legal and regulatory comparison

Map relevant statutes, regulations, court decisions, human-rights standards, professional requirements, and institutional policies by jurisdiction and historical period.

Goal 6 — Accountability tracking

Identify investigations, findings, recommendations, settlements, judgments, corrective actions, compensation programs, and unresolved oversight questions.

Goal 7 — Responsible AI

Ensure that the platform supports human investigation without automatically determining guilt, medical necessity, legal liability, or the credibility of an individual complainant.

### 4\. Scope of Investigation

The project will use separate analytical categories to avoid conflating different medical, legal, and civil-rights questions.

| Research domain                    | Investigative focus                                                                                 |
| ---------------------------------- | --------------------------------------------------------------------------------------------------- |
| Reproductive coercion              | Forced or coerced sterilization, contraception without valid consent, reproductive pressure         |
| Informed consent                   | Consent documentation, disclosure, capacity, voluntariness, withdrawal and language access          |
| Intersex medical interventions     | Nonconsensual or medically unnecessary interventions, patient autonomy and long-term accountability |
| Conversion practices               | Coercive or harmful practices, applicable law, professional standards and documented outcomes       |
| Gender-identity-related healthcare | Consent, clinical safeguards, nondiscrimination, access, privacy and professional compliance        |
| Human-subject research             | Research authorization, oversight approvals, participant protections and reporting obligations      |
| Civil-rights discrimination        | Unequal treatment, discriminatory policies, retaliation and barriers to remedies                    |
| Institutional governance           | Oversight failures, complaint handling, conflicts of interest and corrective actions                |

The platform will not assume that all practices within any one domain are unlawful. Each investigation must be evaluated under the law and evidence applicable to the specific time, place, institution, and person involved.

### 5\. Proposed Technical Architecture

Conceptual architecture — proposed design, not a deployed IBM product.

```mermaid

flowchart TD
   A["Lawfully Obtained Records"] --> B["Secure Evidence Intake"]
   B --> C["Document Parsing and OCR"]
   C --> D["Source Verification and Metadata"]
   D --> E["Evidence Classification"]
   E --> F["Knowledge Graph and Entity Resolution"]
   E --> G["Financial Forensics Engine"]
   E --> H["Consent and Medical Ethics Review"]
   E --> I["Legal and Regulatory Mapping"]
   F --> J["Cross-Case Intelligence Layer"]
   G --> J
   H --> J
   I --> J
   J --> K["Human Research and Legal Review"]
   K --> L["Auditable Findings and Reports"]
   L --> M["Oversight and Corrective Action Tracking"]
```

### 5.1 Evidence intake and preservation

The intake layer will support authorized documents such as:

* Court judgments, pleadings, and official case records.

* Legislative hearing transcripts.

* Government audit and inspector-general reports.

* Public budgets and appropriations.

* Procurement and contract records.

* Publicly released institutional policies.

* Medical consent templates and oversight guidance.

* Publicly available research and historical archives.

* Lawfully obtained complaints and records supplied with appropriate authorization.

Each source will receive a unique evidence identifier, ingestion timestamp, source description, document version, and cryptographic integrity hash.

Sensitive personal records will require additional access controls and privacy review before processing.

### 5.2 Artificial-intelligence document analysis

The AI layer will use document classification, optical character recognition, natural-language processing, semantic search, and structured information extraction.

It will identify potential references to:

* Consent and refusal.

* Sterilization and contraception.

* Coercion, pressure, threats, and incentives.

* Funding, grants, contracts, and payments.

* Medical oversight and approval.

* Complaints, investigations, and disciplinary action.

* Discrimination and retaliation.

* Corrective action and compensation.

The system will preserve the original source text alongside extracted summaries. AI-generated interpretations will be labeled as machine-generated research suggestions until reviewed by a qualified person.

### 5.3 Cross-case knowledge graph

The knowledge graph will represent relationships among:

* Institutions and agencies.

* Individual actors where their public or authorized records are relevant.

* Policies and legal authorities.

* Medical facilities and providers.

* Contracts, grants, appropriations, and payment records.

* Investigations, complaints, judgments, and audit findings.

* Dates, jurisdictions, and documented events.

A relationship will only be treated as established when supported by a source. The platform will distinguish direct documentary evidence from inferred or unresolved connections.

### 5.4 Financial-forensics engine

This module will examine whether financial structures or management practices may have created pressure or incentives associated with harmful conduct.

It will analyze:

* Budget allocations and spending patterns.

* Provider contracts and payment structures.

* Performance targets and program quotas.

* Bonuses, rewards, promotions, and sanctions.

* Procurement and vendor relationships.

* Reimbursement and billing policies.

* Institutional cost-saving arguments.

* Compensation and remediation expenses.

The system will distinguish a documented payment from a proven incentive, and a documented cost-saving rationale from an established motive for a particular act.

### 5.5 Medical ethics and consent analysis

The platform will compare available consent records and procedures with the applicable standards for the jurisdiction and period under review.

Potential indicators include:

* Missing or incomplete consent forms.

* Missing signatures or required approvals.

* Inadequate disclosure of risks and alternatives.

* Evidence of threats, pressure, deception, or improper inducements.

* Language-access deficiencies.

* Lack of an appropriate opportunity to refuse.

* Missing postoperative or follow-up documentation.

* Inadequate protections for minors or people with impaired decision-making capacity.

These are screening indicators, not automatic proof of unlawful conduct.

### 5.6 Legal and regulatory intelligence

The legal mapping engine will identify relevant laws and standards and record:

* Jurisdiction.

* Effective dates.

* Amendments and repeals.

* Applicable legal requirements.

* Court interpretations.

* Official findings.

* Available remedies.

* Outstanding legal questions.

The system will not provide an automated legal verdict. Qualified legal professionals must review jurisdiction-specific conclusions.

### 6\. Financial Pressure and Institutional Incentive Investigation

A major research component will investigate whether financial structures contributed to coercive or discriminatory practices.

The project will test specific hypotheses rather than assume financial misconduct.

| Financial mechanism       | Evidence sought                                               | What it may establish                                                 |
| ------------------------- | ------------------------------------------------------------- | --------------------------------------------------------------------- |
| Per-procedure payments    | Contracts, invoices, payment schedules                        | Whether payments were made and under what terms                       |
| Performance incentives    | Bonus records, promotion criteria, targets                    | Whether compensation or career rewards were tied to outcomes          |
| Quotas and targets        | Internal directives, facility reports, performance dashboards | Whether numerical goals were imposed                                  |
| Cost-reduction policies   | Budgets, policy memoranda, cost analyses                      | Whether savings were an institutional objective                       |
| Procurement relationships | Bids, contracts, vendor correspondence                        | Which suppliers and institutions were involved                        |
| Grant conditions          | Grant agreements, monitoring reports                          | Whether funding had conditions or measurable performance requirements |
| Compensation programs     | Appropriations, payment records, eligibility rules            | How governments addressed documented or alleged harm                  |

### Initial research priorities

Peru: Examine the relationship between official program targets, health-worker quotas, incentives, food or medicine offers, consent procedures, and oversight findings. Official congressional and ombudsman materials will be prioritized. www2.congreso.gob.pe +1

California: Examine provider contracts, payments, consent deficiencies, approval procedures, and the relationship between prison administration and medical oversight. The 2014 audit is the primary starting point. information.auditor.ca.gov +1

North Carolina and Alberta: Examine historical board records, institutional budgets, government policy, cost arguments, and subsequent compensation. Historical financial arguments must not be assumed to explain every individual case. NC DOA +2

Japan: Examine government policy, legislative records, administrative guidance, historical public-health objectives, and the later compensation and accountability process. The Supreme Court ruling provides a key primary legal source. courts.go.jp +1

Greenland and Denmark: Examine procurement, medical records, government correspondence, consent practices, historical demographic policy, and inquiry findings. The disputed question of systematic intent will remain explicitly unresolved unless supported by reliable evidence. OHCHR +1

### 7\. Evidence Classification and Verification Framework

Every claim in the system will receive an evidence-status label.

| Label                        | Meaning                                                                                                         |
| ---------------------------- | --------------------------------------------------------------------------------------------------------------- |
| Verified official finding    | Finding expressly made by a court, government audit, official inquiry, or competent public authority            |
| Judicial determination       | A court's actual holding or finding, limited to the issues it decided                                           |
| Documented historical record | Supported by authentic historical records or authoritative archives                                             |
| Corroborated reporting       | Supported by multiple independent and credible reports                                                          |
| Reported allegation          | A claim made by a witness, complainant, journalist, or other source that has not been independently established |
| Investigative hypothesis     | A question or possible connection requiring additional evidence                                                 |
| Disputed interpretation      | A conclusion for which credible sources disagree                                                                |
| Unknown or unavailable       | Evidence is missing, inaccessible, incomplete, or insufficient                                                  |

The system will never upgrade an allegation into a verified finding merely because multiple documents repeat the same original allegation.

It will track source independence, publication date, document provenance, contradictory evidence, and any corrections or retractions.

### 8\. Research Questions and Testable Hypotheses

The project will test the following questions:

RQ1: Do documented program quotas or performance targets correlate with increased reports of coercion or inadequate consent?

RQ2: Were provider payments, bonuses, or institutional rewards connected to the number or type of procedures performed?

RQ3: Did oversight agencies receive warnings or complaints before serious violations were publicly identified?

RQ4: Were consent procedures modified, bypassed, or inconsistently enforced across facilities or populations?

RQ5: Did institutional financial pressures influence the design or administration of programs?

RQ6: Were people from particular populations disproportionately affected, and what evidence explains that pattern?

RQ7: Did corrective actions address the underlying institutional practices or only individual incidents?

RQ8: Are there recurring governance failures across jurisdictions despite differences in law, culture, medical practice, and historical context?

### Hypothesis-testing safeguards

* Correlation will not be treated as causation.

* A shared vendor or agency will not establish coordination.

* Similar policies will not establish a common motive.

* Demographic disparity will trigger further analysis, not an automatic conclusion of discrimination.

* Financial benefit will not automatically establish financial motive.

* Missing documentation will be treated as a documentation gap, not proof that an event did not occur or that it was unlawful.

### 9\. IBM Technology Alignment

The project proposes evaluating IBM technologies where technically and commercially appropriate. These are proposed technology options, not confirmed IBM partnerships, product commitments, or endorsements.

| Technical requirement             | Potential IBM technology area                               |
| --------------------------------- | ----------------------------------------------------------- |
| AI-assisted document analysis     | IBM watsonx.ai                                              |
| Enterprise knowledge retrieval    | IBM watsonx platform                                        |
| Secure data governance            | IBM watsonx.governance                                      |
| Data integration and analytics    | IBM data integration and analytics technologies             |
| Hybrid-cloud deployment           | IBM hybrid cloud and Red Hat OpenShift                      |
| Identity and access management    | Enterprise identity and security controls                   |
| Audit and monitoring              | Enterprise logging, monitoring, and security capabilities   |
| Graph-based relationship analysis | Graph database or compatible knowledge-graph infrastructure |

The final technical stack will be selected after an architecture review, security assessment, licensing analysis, and evaluation of the availability of each proposed capability.

### 10\. Innovation and Research Contribution

UGP-CRMEIAS is intended to contribute a unified investigative methodology rather than simply create another document-search application.

Its proposed innovations include:

* Evidence-status-aware AI: Every finding retains a distinction between court-established facts, official findings, testimony, reporting, and hypotheses.

* Financial-to-medical evidence linkage: The system connects authorized financial records with medical oversight and consent records without assuming causation.

* Cross-jurisdictional accountability mapping: Historical and contemporary programs can be compared while preserving differences in applicable law.

* Institutional warning analysis: The system can identify documented warnings, complaints, audit recommendations, and subsequent institutional responses.

* Evidence-gap detection: Investigators can identify missing documents that would materially affect a conclusion.

* Reproducible research: Researchers can recreate a finding from the original source, extraction history, and review record.

* Human-controlled decision-making: Legal conclusions, clinical judgments, and determinations of responsibility remain with qualified human decision-makers.

### 11\. Initial Demonstration Pilot

The first pilot will use five historical research cases already identified in the preliminary research:

* Peru's reproductive sterilization program.

* California prison sterilization procedures.

* North Carolina's former eugenics program.

* Japan's former Eugenic Protection Act.

* Greenland and Denmark's historical contraception practices.

These cases provide different evidence types and legal contexts for testing the architecture.

### Pilot deliverables

* A searchable collection of authorized source documents.

* A source-linked case chronology for each jurisdiction.

* An institutional relationship map.

* A financial-evidence register.

* A medical-consent and oversight review matrix.

* A legal-authority and accountability register.

* An evidence-gap report.

* A demonstration of explainable AI-assisted cross-case analysis.

The pilot will not publish personal medical information or identify private individuals without a lawful basis and appropriate authorization.

### 12\. Development Roadmap

Proposed 12-month research schedule, subject to funding, access, staffing, and institutional approval.

* Phase 1 — Requirements and research governance

   Months 1–2

   * Establish research scope and definitions.

   * Create the evidence classification standard.

   * Define privacy, security, and human-review requirements.

   * Select pilot jurisdictions and source repositories.

   * Identify legal and medical ethics reviewers.

   Deliverable: Approved research and technical requirements.

* Phase 2 — Evidence infrastructure

   Months 3–4

   * Develop secure document intake.

   * Implement source metadata and integrity checks.

   * Build OCR and document classification.

   * Establish access controls and audit logging.

   Deliverable: Evidence repository prototype.

* Phase 3 — AI and relationship intelligence

   Months 5–7

   * Develop source-grounded search and extraction.

   * Implement entity and institution resolution.

   * Build the cross-case knowledge graph.

   * Implement financial and consent-analysis workflows.

   Deliverable: Functional analytical prototype.

* Phase 4 — Historical case pilot

   Months 8–9

   * Process the five initial research cases.

   * Build timelines and financial registers.

   * Compare official findings and allegations.

   * Identify unresolved evidence gaps.

   Deliverable: Five-case demonstration and research report.

* Phase 5 — Independent validation

   Months 10–11

   * Conduct legal and medical ethics review.

   * Test false-positive and false-negative rates.

   * Evaluate privacy and security controls.

   * Perform adversarial testing of AI-generated conclusions.

   Deliverable: Independent validation and risk report.

* Phase 6 — Pilot evaluation and expansion plan

   Month 12

   * Evaluate the pilot against defined metrics.

   * Document technical limitations.

   * Prepare deployment and maintenance requirements.

   * Recommend whether to expand to additional jurisdictions.

   Deliverable: Final pilot report and deployment recommendation.

### 13\. Evaluation Metrics

The project will be evaluated using measurable criteria.

| Metric                                      | Proposed pilot target               |
| ------------------------------------------- | ----------------------------------- |
| Extracted claims with source references     | 100%                                |
| Documents with recorded provenance          | 100%                                |
| Human-reviewed high-impact findings         | 100%                                |
| Correct classification of evidence status   | At least 95% on a reviewed test set |
| Entity-resolution precision                 | At least 90% on a reviewed test set |
| Material source-citation accuracy           | At least 95% on a reviewed test set |
| Critical privacy or access-control failures | Zero accepted                       |
| Unreviewed automated legal conclusions      | Zero                                |
| Reproducibility of sampled findings         | 100%                                |

These are proposed acceptance targets, not achieved performance claims. Evaluation results must report sample size, test-set composition, confidence intervals where appropriate, and known limitations.

### 14\. Privacy, Human Rights, and Responsible AI Safeguards

The system will be designed around the following requirements:

* No unauthorized access to medical, government, or private institutional records.

* No use of stolen, unlawfully obtained, or improperly disclosed personal data.

* Encryption in transit and at rest.

* Role-based access and least-privilege permissions.

* Data minimization and retention limits.

* De-identification or pseudonymization when appropriate.

* Special protections for minors and vulnerable populations.

* No automated public accusations or guilt determinations.

* No automated medical recommendations or treatment decisions.

* No profiling of individuals based on gender identity, sex characteristics, medical history, or other sensitive attributes.

* Human review of high-impact findings.

* Documented procedures for correcting inaccurate records and disputed findings.

* Independent legal, medical ethics, privacy, and security review.

The platform must not become a tool for harassment, discrimination, political targeting, retaliation, or unlawful surveillance.

### 15\. Legal and Regulatory Framework

The project will maintain a jurisdiction-specific legal framework rather than apply one universal rule to every country.

Relevant areas for legal review include:

* Informed-consent requirements.

* Medical professional standards.

* Human-subject research protections.

* Civil-rights and antidiscrimination law.

* Patient confidentiality and medical privacy.

* Data protection and cross-border data transfers.

* Public-records and archival access laws.

* Government accountability and administrative law.

* Institutional recordkeeping and audit obligations.

* Legal remedies and compensation mechanisms.

For United States research, the project may need to evaluate applicable federal and state privacy rules, the Common Rule where applicable, civil-rights protections, and relevant medical licensing and consent requirements. Applicability must be determined by qualified counsel for each research activity.

For international research, the project will evaluate the laws of each jurisdiction and relevant human-rights instruments, including applicable protections against discrimination, nonconsensual medical treatment, and unlawful interference with privacy and bodily autonomy.

### 16\. Risk Register

| Risk                                      | Potential consequence               | Mitigation                                                         |
| ----------------------------------------- | ----------------------------------- | ------------------------------------------------------------------ |
| False allegations generated by AI         | Reputational and legal harm         | Source-linked findings and mandatory human review                  |
| Incomplete historical records             | Incorrect conclusions               | Explicit uncertainty and missing-evidence registers                |
| Duplicate or dependent sources            | False appearance of corroboration   | Source-independence analysis                                       |
| Political or ideological bias             | Distorted research outcomes         | Balanced test sets and independent review                          |
| Sensitive medical data exposure           | Privacy violations                  | Data minimization, encryption and strict access control            |
| Incorrect legal comparison                | Misclassification of lawful conduct | Jurisdiction-specific legal review                                 |
| Financial correlation mistaken for motive | Unsupported accusations             | Separate evidence of payment, incentive, and motive                |
| Model hallucination                       | Fabricated or distorted findings    | Retrieval-grounded outputs and source verification                 |
| Institutional resistance                  | Limited access to records           | Public-records research and transparent methodology                |
| Misuse for discrimination                 | Harm to individuals or groups       | Restricted access, governance controls and prohibited-use policies |

### 17\. Proposed Research Team

The initial research team should include:

* Principal investigator / project director.

* AI and data architecture lead.

* Digital-forensics specialist.

* Financial-forensics researcher.

* Civil-rights and human-rights legal researcher.

* Medical ethics specialist.

* Privacy and cybersecurity specialist.

* Historical research and archival specialist.

* Independent validation and evaluation lead.

Current staffing status: These positions are proposed. No appointments, employment agreements, or institutional commitments are claimed.

### 18\. Proposed Funding and Resource Plan

A final budget will depend on the IBM technology stack, hosting model, staffing arrangements, data-access costs, and independent validation requirements.

The following is an illustrative planning range for a 12-month pilot, not a vendor quote or secured funding request.

| Resource category                      | Illustrative range |
| -------------------------------------- | ------------------ |
| AI and software engineering            | $60,000–$120,000   |
| Data engineering and digital forensics | $25,000–$55,000    |
| Legal and medical ethics review        | $20,000–$45,000    |
| Cybersecurity and privacy assessment   | $15,000–$30,000    |
| Cloud infrastructure and software      | $5,000–$20,000     |
| Independent validation                 | $10,000–$25,000    |
| Research and archival expenses         | $5,000–$15,000     |
| Illustrative total                     | $140,000–$310,000  |

The project may pursue an initial lower-cost feasibility phase using public records, open-source tools, and existing computing resources. IBM technology access, research collaboration, cloud credits, or other in-kind support would need to be separately requested and approved.

No funding, donated services, or IBM sponsorship is currently represented as secured.

### 19\. Expected Outcomes and Public Benefit

If successfully developed and validated, UGP-CRMEIAS could provide:

* Faster and more reproducible investigations of historical and contemporary institutional conduct.

* Better visibility into the relationship between funding structures, performance expectations, and medical oversight.

* More reliable identification of consent-process deficiencies.

* Better documentation of government and institutional responses to complaints.

* Improved access to organized public evidence for researchers and accountability organizations.

* Stronger safeguards against unsupported allegations and automated misclassification.

* A reusable framework for investigating institutional misconduct across jurisdictions.

The long-term goal is to support evidence-based accountability while protecting the rights, privacy, and dignity of the people whose experiences are being investigated.

### 20\. Requested IBM Collaboration

The project respectfully requests that IBM consider:

* A preliminary technical review of the proposed architecture.

* Evaluation of suitable watsonx and hybrid-cloud technologies.

* Guidance on secure AI document analysis and source-grounded retrieval.

* Advice on knowledge-graph design and financial-forensics integration.

* Potential access to a research or innovation collaboration pathway.

* Technical mentorship or evaluation support.

* Consideration of a controlled pilot, subject to institutional review and available resources.

The proposed collaboration would begin with a feasibility assessment. Any IBM involvement, product availability, research partnership, or financial support would require separate review and approval.

### 21\. Final Research Position

UGP-CRMEIAS is not intended to establish a predetermined political or medical conclusion. It is designed to establish a reliable method for finding out what happened, what evidence supports each conclusion, who had institutional responsibility, how financial and administrative structures operated, and whether corrective action followed.

The project recognizes that the historical cases differ significantly. Some include court-established violations, some include official audit findings, some include government acknowledgments, and others remain disputed or require additional investigation.

The proposed system will preserve those distinctions.

Its guiding principle is:

No allegation without evidence. No finding without traceable sources. No financial-motive conclusion without financial evidence. No automated determination of guilt. No institutional accountability assessment without an opportunity for qualified human review.

### 22\. Submission Readiness and Outstanding Requirements

Before sending this to IBM, the following items should be completed:

* Confirm the applicant's legal name and contact details.

* Decide whether the applicant will submit as an individual or through a registered organization.

* Identify a technical lead or research collaborator.

* Prepare a one-page public abstract.

* Prepare an initial technical architecture diagram and prototype plan.

* Confirm the intended IBM program or research contact.

* Obtain legal and medical ethics review of the proposed research scope.

* Verify the source documents and preserve copies of the primary records.

* Replace illustrative budget ranges with a documented budget.

* Attach a data protection and research governance plan.

Important submission note: This is a research collaboration proposal, not a claim of an existing IBM program or a confirmed DARPA solicitation. IBM and DARPA have separate application and evaluation processes. A DARPA submission would need to be adapted to a specific active solicitation and its requirements.

### 23\. Selected Preliminary Evidence Base

The following sources provide the starting point for the five-case pilot:

* Peru — Congressional investigation and official oversight: Peruvian congressional investigative findings and the U.S. congressional hearing record. www2.congreso.gob.pe +2

* California — State Auditor: California State Auditor Report 2013-120, June 2014. information.auditor.ca.gov +1

* North Carolina — State records: North Carolina Governor's Task Force for Compensation of Eugenics Board Victims and associated archival records. NC DOA +1

* Japan — Supreme Court: 2024 Supreme Court ruling on the former Eugenic Protection Act. courts.go.jp +1

* Greenland and Denmark — UN and independent reporting: UN human-rights experts' October 2026 statement and Associated Press investigation. OHCHR +1

End of proposal.
 

### UGP-CRMEIAS — Cross-reference investigation

Universal Gender Programs Civil Rights, Medical Ethics & Institutional Accountability Intelligence System

The most important discovery in this cross-reference is that some abuses were not merely isolated medical mistakes. In several historical programs, the evidence connects government policy, institutional performance targets, financial incentives, medical decision-making and inadequate oversight.

There are also important differences between countries. We should not assume that the same motive existed everywhere.

### 1\. Cross-reference of the strongest financial and institutional connections

Primary-source evidence located

| Case                               | Government / institution                     | Financial or administrative connection                                                 | Evidence status                                                    |
| ---------------------------------- | -------------------------------------------- | -------------------------------------------------------------------------------------- | ------------------------------------------------------------------ |
| Peru, 1995–2000                    | Ministry of Health                           | Sterilization targets, worker bonuses, institutional rewards and sanctions             | Congressional investigation and official findings                  |
| California prisons, 2005–2013      | Corrections and contracted medical providers | Payments to contracted doctors; inadequate consent safeguards                          | State audit                                                        |
| North Carolina, 1929–1974          | Eugenics Board                               | Government-funded institutional sterilization program                                  | State archives and compensation task force                         |
| Alberta, 1929–1972                 | Provincial Eugenics Board                    | Public institutional and social-welfare cost arguments                                 | Government acknowledgment and historical research                  |
| Japan, 1948–1996                   | National government                          | State policy based on eugenic objectives and population-quality ideology               | Supreme Court finding                                              |
| Greenland, principally 1960s–1970s | Danish and Greenlandic health authorities    | Population-growth rationale reported; institutional responsibility and intent disputed | Official acknowledgment, independent investigation and UN scrutiny |

### Connection A: Peru — performance targets became coercive incentives

Strong documented financial-pressure evidence

This is one of the clearest examples of how financial and administrative pressure can distort a healthcare program.

The February 25, 1998 U.S. congressional hearing contains several important pieces of evidence:

* Health workers reportedly received up to 30 soles for each woman sterilized.

* National and regional targets were translated into individual quotas.

* Some workers reportedly faced sanctions for failing to meet quotas.

* Food and other benefits were reportedly offered to encourage sterilization.

* Officials received regular reports about sterilization performance.

The Peruvian Congressional investigative subcommittee's findings are particularly important: it described program targets becoming mandatory quotas, with incentives for staff and health facilities that sterilized more people. www2.congreso.gob.pe +2

Original records

* [1998 U.S. Congressional hearing — The Peruvian Population Control Program](https://chrissmith.house.gov/uploadedfiles/1998.02.25_the_peruvian_population_control_program.pdf?utm_source=chatgpt.com)

* [Peruvian Congressional investigative report](https://www2.congreso.gob.pe/sicr/apoycomisiones/informes.nsf/InformesPorComision/c405450deb310e6c05256cbe0076a35e?Click=&OpenDocument=&utm_source=chatgpt.com)

* [USAID testimony on program reforms](https://www.govinfo.gov/content/pkg/CHRG-106hhrg65471/pdf/CHRG-106hhrg65471.pdf?utm_source=chatgpt.com)

Financial cross-reference:

### How the incentive structure worked

National policy targets

Government-defined sterilization objectives

Regional and hospital quotas

Targets distributed to health facilities and personnel

Individual financial and career incentives

Reported cash bonuses, rewards and sanctions

Patient pressure and consent failures

Documented consequences of the incentive system

Missing link worth investigating: Who authorized each performance target, who approved the bonus arrangements, how were payments recorded, and which officials received the performance reports?

Those questions connect the individual healthcare worker to the larger institutional chain.

USAID subsequently reported reforms eliminating quotas, targets and incentives, and withheld fiscal-year 1999 funds pending evidence of reform implementation. GovInfo +1

This is an especially important funding trail because it shows that an external funding institution recognized the need for financial safeguards.

### Connection B: California — prison medicine and financial incentives

The California State Auditor's June 2014 Report 2013-120 is a primary document.

Between 2005–06 and 2012–13:

* 144 female inmates underwent sterilization procedures.

* 39 had documented deficiencies in the informed-consent process.

* 27 lacked the required physician signature on the consent form.

* 18 had potential waiting-period violations.

* Six had both deficiencies.

The auditor concluded that the prison health system had failed to ensure lawful consent. information.auditor.ca.gov

A separate financial lead:

An investigative report by the Center for Investigative Reporting found that California paid contracted doctors $147,460 for sterilization procedures from 1997 to 2010. It also reported a physician's statement that sterilization could save the state welfare costs. KQED +1

This deserves careful treatment:

* The payments establish that money changed hands for contracted procedures.

* The physician's statement is evidence of his expressed financial rationale.

* Neither fact alone proves that California's government adopted a policy of sterilizing inmates to save welfare costs.

Overlooked questions:

* Were doctors compensated per procedure or through broader contracts?

* Who approved the medical orders?

* Did the state evaluate long-term cost savings?

* Were patients informed about alternatives?

* Did prison administrators investigate complaints?

* Were the same providers responsible for multiple questionable procedures?

The underlying audit and payment records should be compared, rather than treating the two sources as proof of a single coordinated motive.

### Connection C: North Carolina and Alberta — institutional cost arguments

The historical U.S. and Canadian eugenics programs share a documented ideological and administrative pattern.

North Carolina

The state created a Eugenics Board and authorized sterilization decisions through an institutional process.

The state later established a compensation task force, with access to:

* Eugenics Board minutes.

* Individual case files.

* Historical hearing records.

* County-level sterilization data.

* Compensation recommendations.

The official state website provides these records and the final task-force report. NC DOA

Alberta

Alberta's program operated from 1929 until 1972. The Ontario Human Rights Commission's historical account reports more than 2,800 sterilizations, lawsuits by over 800 people, a provincial apology in 1999 and financial compensation. Ontario Human Rights Commission

Financial motive evidence

Historical research identifies a recurring argument made by eugenics advocates: sterilization would reduce the public costs of institutional care and future social services.

A scholarly historical study specifically discusses California and Alberta politicians' interest in anticipated government savings. Library and Archives Canada +1

The important distinction is that this establishes a documented political and economic rationale, not proof that every individual board member acted primarily for financial reasons.

### Connection D: Japan — national policy and institutional ideology

Supreme Court finding

Japan's Eugenic Protection Act operated from 1948 to 1996.

The Supreme Court's 2024 judgment established that the former eugenic provisions violated constitutional protections and that the state could be held responsible.

The judgment's historical account identifies:

* Approximately 48 years of implementation.

* Government promotion of eugenic operations.

* At least 25,000 people sterilized under the relevant statutory provisions.

* Official guidance that contemplated restraint, anesthesia, deception or other means in certain circumstances.

The Court also addressed the state's attempt to rely on limitation periods to defeat compensation claims. courts.go.jp +1

Motive analysis

The historical scholarship identifies two important ideological drivers:

* Concern about overpopulation.

* The purported improvement of the genetic quality of the population.

These are documented historical rationales, not a modern medical justification. DOI +1

Financial question still open: How much did the national and prefectural governments spend administering the program, and how much was subsequently allocated to victim compensation?

Those figures need to be extracted from government budget and compensation records rather than estimated.

### Connection E: Greenland — population policy, colonial administration and accountability

This case has an important evidentiary complication.

An independent investigation documented hundreds of women and girls who received contraception without informed consent. The historical scale and the impact on Inuit communities are significant. AP News

However, a 2026 UN expert statement discusses a dissenting report from two members of the government-appointed expert group. That report said there was insufficient empirical evidence to conclude that Danish or Greenlandic authorities had pursued an intentional, systematic policy of inserting IUDs without consent to limit population growth.

The UN experts emphasized the need for a complete and accurate historical record and meaningful remedies. OHCHR

What should be cross-referenced:

* Danish healthcare administration.

* Greenland's colonial and political relationship with Denmark.

* Population-growth policy discussions.

* Hospital and clinical records.

* Consent documentation.

* School and public-health campaigns.

* Government correspondence.

* Compensation eligibility and payments.

The population-control explanation must remain a historical hypothesis to be tested against actual government directives, rather than assumed to be the proven motive of every procedure.

### 2\. Cross-case patterns and missing links

These are the connections I would investigate across all six programs.

| Pattern                       | Peru                       | California                               | NC / Alberta                          | Japan                                    | Greenland                            |
| ----------------------------- | -------------------------- | ---------------------------------------- | ------------------------------------- | ---------------------------------------- | ------------------------------------ |
| Government authority          | Yes                        | Yes                                      | Yes                                   | Yes                                      | Yes                                  |
| Medical institutions          | Yes                        | Yes                                      | Yes                                   | Yes                                      | Yes                                  |
| Administrative targets        | Documented                 | Not established as a sterilization quota | Board-based decisions                 | Statutory criteria                       | Not established as a common quota    |
| Financial incentives          | Reported and investigated  | Contract payments                        | Public expenditure and cost arguments | Not established as per-procedure bonuses | Not established                      |
| Population-control rationale  | Documented                 | Not established as official state policy | Eugenic population ideology           | Explicit eugenic ideology                | Disputed                             |
| Informed-consent failures     | Documented                 | Auditor documented deficiencies          | Documented historically               | Judicially established                   | Documented in individual experiences |
| Accountability after exposure | Reforms and investigations | Audit and later policy scrutiny          | Apologies and compensation            | Supreme Court and compensation           | Apology and compensation process     |

### 3\. Financial pressures and motives: what the evidence supports

There are five distinct types of motive that should be tested.

1\. Direct financial incentives

Staff or contractors benefit financially from the number of procedures completed.

Peru: documented

Reported per-patient bonuses and institutional rewards.

2\. Institutional cost reduction

Government officials believe reducing future institutional or welfare expenditure will save money.

Historical eugenics advocacy: documented

Particularly relevant to California and Alberta.

3\. Ideological and demographic objectives

Government policies seek to influence who reproduces or the characteristics of the future population.

Japan: documented

Explicit eugenic objectives in legislation and judicial history.

4\. Institutional performance pressure

Managers reward compliance with targets, even when targets conflict with individual rights.

Peru: documented

A particularly important governance failure.

5\. Colonial and population policy

Government health systems operate within broader demographic and political relationships.

Greenland: requires further testing

Historical population concerns are documented, but intentional systematic coercive policy remains disputed.

### 4\. The missing evidence connections I would pursue

These are investigative leads, not established findings of wrongdoing.

| Priority | Missing evidence                             | Why it matters                                                              |
| -------- | -------------------------------------------- | --------------------------------------------------------------------------- |
| 1        | Government budget appropriations             | Establishes who financed the programs.                                      |
| 2        | Hospital contracts and payment schedules     | Reveals payment structures and potential conflicts of interest.             |
| 3        | Performance reports and quotas               | Shows whether patient outcomes were subordinated to numerical targets.      |
| 4        | Internal emails and meeting minutes          | May identify who authorized or objected to practices.                       |
| 5        | Medical consent forms                        | Tests whether consent was genuinely voluntary.                              |
| 6        | Patient complaints and whistleblower records | Shows whether institutions knew about problems.                             |
| 7        | Audit findings and corrective-action records | Establishes whether officials responded to known failures.                  |
| 8        | Demographic targeting criteria               | Identifies whether particular populations were disproportionately selected. |
| 9        | Government reimbursement records             | Identifies financial relationships between agencies and providers.          |
| 10       | Compensation and settlement records          | Measures the financial consequences of institutional wrongdoing.            |

### 5\. The motive investigation

I would not assign a motive to a person simply because they worked for an institution involved in a historical abuse.

Instead, I would seek evidence in this order:

* What policy did the institution officially adopt?

* Who proposed the policy?

* Who approved its funding?

* Who benefited financially?

* Who received performance reports?

* Who knew about complaints?

* Who had authority to stop the conduct?

* What happened after the complaints became known?

* Were records destroyed, withheld or altered?

* Did the institution change its practices after exposure?

That approach can distinguish policy intent, financial incentives, institutional negligence and individual misconduct.

### 6\. Proposed investigative evidence map

### Institutional accountability chain

Government policy

Legislation, executive orders, demographic objectives

Funding and procurement

Budgets, grants, contracts, reimbursements

Institutional management

Quotas, performance metrics, supervision

Medical implementation

Patient selection, informed consent, treatment records

Complaints and oversight

Whistleblowers, inspections, audits, litigation

Accountability

Legal findings, restitution, compensation and reform

### 7\. My priority source collection

These are the documents I would preserve first:

* [Peruvian Population Control Program — 1998 congressional hearing](https://chrissmith.house.gov/uploadedfiles/1998.02.25_the_peruvian_population_control_program.pdf?utm_source=chatgpt.com)

* [Peruvian Congressional investigative findings](https://www2.congreso.gob.pe/sicr/apoycomisiones/informes.nsf/InformesPorComision/c405450deb310e6c05256cbe0076a35e?Click=&OpenDocument=&utm_source=chatgpt.com)

* [California State Auditor Report 2013-120](https://information.auditor.ca.gov/pdfs/reports/2013-120.pdf?utm_source=chatgpt.com)

* [North Carolina Eugenics Board archives and compensation task force](https://www.doa.nc.gov/about/special-programs/office-justice-sterilization-victims/governor%E2%80%99s-task-force?utm_source=chatgpt.com)

* [Ontario Human Rights Commission — Alberta sterilization history](https://www.ohrc.on.ca/en/policy-preventing-discrimination-based-mental-health-disabilities-and-addictions/appendix?utm_source=chatgpt.com)

* [Japan Supreme Court judgment](https://www.courts.go.jp/english/Judgments/search/2066/index.html?utm_source=chatgpt.com)

* [UN — Greenland contraception accountability, October 2026](https://wapsphp.test.ohchr.un-icc.cloud/en/press-releases/2026/10/greenlandic-forced-contraception-case-un-experts-say-truth-remedy-and?utm_source=chatgpt.com)

* [Historical research on financial motivations in eugenics](https://central.bac-lac.gc.ca/.item?app=Library&id=MR90229&oclc_number=1019487121&op=pdf&utm_source=chatgpt.com)

### 8\. Overall investigative conclusion

Three particularly important connections emerge:

* Peru: Numerical targets, financial incentives and institutional pressure were linked to coercive reproductive practices.

* California: Contracted medical services, prison administration and failures in informed consent created an accountability problem.

* Historical eugenics programs: Government officials and advocates explicitly used population-quality and public-cost arguments to justify coercive policies.

Japan provides a particularly strong judicial record of state responsibility. Greenland demonstrates why independent scrutiny, complete historical records and careful examination of competing findings are essential.

These are different historical systems. There is not yet evidence establishing a single international organization coordinating them.